# CellCentric funding: rounds and investors

> CellCentric has raised $525M across 8 rounds since 2013. Investors include RA Capital Management, Forbion Capital Partners and Venrock Healthcare Capital...

Source: https://millionrounds.com/company/cellcentric (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Growth startup](https://millionrounds.com/companies)

# Who invested in *CellCentric*

8 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech Healthcare Pharma

Raised 6 months ago

Funding summary Updated 26 Oct 2026

**$525M** raised across 8 rounds since 2013, from 8 sources

**$6.5M** Venture **$26M** Round **$21M** Round **$3.0M** Round **$64M** Round **$120M** Series C **$65M** Round **$220M** Growth

- **Latest round:** Growth, $220M May 2026
- **Led by:** Venrock Healthcare Capital Partners
- **Step-up i:** 3.4×
- **Investors:** 9 (2 led)

See who backed them

## The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2013 2015 2017 2019 2021 2023 2025

**$6.5M** Venture

**$26M** Round

**$21M** Round

**$3.0M** Round

**$64M** Round

**$120M** Series C

**$65M** Round

**$220M** Growth

- **First round:** Venture, $6.5M
- **Biggest round:** $220M
- **Usual gap between rounds:** 10 months

## The rounds

- **May 2026** Growth **$220M** *5 new* *2 returning* [Venrock Healthcare Capital Partners](https://millionrounds.com/fund/venrock-healthcare-capital-partners) Lead [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) [Fidelity](https://millionrounds.com/fund/fidelity) [Sofinnova Partners](https://millionrounds.com/fund/sofinnova-partners) [Forbion Capital Partners](https://millionrounds.com/fund/forbion-capital-partners) [Pfizer](https://millionrounds.com/fund/pfizer) [HBM Healthcare](https://millionrounds.com/fund/hbm-healthcare) Reported by Ventureburn
- **Jan 2026** Round **$65M** No investor was named in the report. Shares issued, filed with Companies House (SH01); no report of this raise yet
- **May 2025** Series C **$120M** *4 new* [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) Lead [Forbion Capital Partners](https://millionrounds.com/fund/forbion-capital-partners) [Avego Bioscience Capital](https://millionrounds.com/fund/avego-bioscience-capital) [BrightEdge](https://millionrounds.com/fund/brightedge) Reported by TechStartups
- **Jul 2024** Round **$64M** No investor was named in the report. Shares issued, filed with Companies House (SH01); no report of this raise yet
- **Aug 2023** Round **$3.0M** No investor was named in the report. Shares issued, filed with Companies House (SH01); no report of this raise yet
- **Dec 2021** Round **$21M** No investor was named in the report. Shares issued, filed with Companies House (SH01); no report of this raise yet
- **May 2018** Round **$26M** No investor was named in the report. Reported by Endpts
- **Jun 2013** Venture **$6.5M** No investor was named in the report. Reported by cellcentric.com

## Funding filed with regulators

CellCentric filed 10 raises, $412M in all. Filings say how much was sold and to how many investors; they never name the investors.

- May 2026 **$160M** UK share allotment
- Jan 2026 **$65M** UK share allotment
- Apr 2025 **$63M** UK share allotment
- Jul 2024 **$64M** UK share allotment
- Aug 2023 **$3.0M** UK share allotment
- Jan 2022 **$1.0M** UK share allotment
- Dec 2021 **$20M** UK share allotment
- Jun 2015 **$477K** UK share allotment
- Jan 2014 **$35M** UK share allotment
- Sept 2013 **$1.1M** UK share allotment

## Founders and team

From CellCentric's own website: 44 on the team.

- **Will West** Chief Executive Officer & Board Member
- **Cate Tucknott** Senior Vice President, Clinical Operations
- **Gail Larkins** Vice President of Global Medical Affairs
- **Jeff Barrus** Vice President of Regulatory Affairs & Quality
- **Sofia Paul** Vice President of Biometrics
- **Debbie Haynes** Chief Operating Officer
- **Jason Cavalier** Chief Financial Officer
- **Lara Meisner** Chief Administrative Officer & US General Counsel
- **Naseer Qayum** Chief Development Officer
- **Neil Pegg** Chief Scientific Officer
- **Tomasz Knurowski** Chief Medical Officer
- **Alison Hood** General Counsel/Head of IP
- **Karen Clegg** Director of Clinical Science & AP Site Head
- **Melissa Frechette** Head of People & Organizational Effectiveness
- **Alan Zulick** Program Director
- **Andrew Hughes** Non-Executive Director, Board Member
- **Ashley Wagner** Director of Clinical Operations
- **Audrey Schumacher-DeVane** Senior Clinical Trials Manager

And 26 more on the team.

## Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

**Venture** 2013 **Round** 2018 **Round** 2021 **Round** 2023 **Round** 2024 **Series C** 2025 **Round** 2026 **Growth** 2026 [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) L [Forbion Capital Partners](https://millionrounds.com/fund/forbion-capital-partners) [Venrock Healthcare Capital Partners](https://millionrounds.com/fund/venrock-healthcare-capital-partners) L [Fidelity](https://millionrounds.com/fund/fidelity) [Sofinnova Partners](https://millionrounds.com/fund/sofinnova-partners) [Pfizer](https://millionrounds.com/fund/pfizer) [HBM Healthcare](https://millionrounds.com/fund/hbm-healthcare) [Avego Bioscience Capital](https://millionrounds.com/fund/avego-bioscience-capital) [BrightEdge](https://millionrounds.com/fund/brightedge)

## Everyone who backed them

[RA Capital Management](https://millionrounds.com/fund/ra-capital-management) Private equity **2** rounds, led 1

[Forbion Capital Partners](https://millionrounds.com/fund/forbion-capital-partners) Private equity **2** rounds

[Venrock Healthcare Capital Partners](https://millionrounds.com/fund/venrock-healthcare-capital-partners) VC firm **1** round, led 1

[Fidelity](https://millionrounds.com/fund/fidelity) VC firm **1** round

[Sofinnova Partners](https://millionrounds.com/fund/sofinnova-partners) VC firm **1** round

[Pfizer](https://millionrounds.com/fund/pfizer) Corporate VC **1** round

[HBM Healthcare](https://millionrounds.com/fund/hbm-healthcare) Growth equity **1** round

[Avego Bioscience Capital](https://millionrounds.com/fund/avego-bioscience-capital) Private equity **1** round

[BrightEdge](https://millionrounds.com/fund/brightedge) Growth equity **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=cellcentric).

## Also claim to have backed them

These 3 firms list CellCentric as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

[Future Planet Capital](https://millionrounds.com/fund/future-planet-capital) VC firm Series D, per its site

[Avego Management](https://millionrounds.com/fund/avego) VC firm Per its own site

[BrightEdge Fund](https://millionrounds.com/fund/brightedge-fund) Corporate VC Per its own site

## Quick answers about CellCentric

### Who invested in CellCentric?

CellCentric's investors include RA Capital Management, Forbion Capital Partners, Venrock Healthcare Capital Partners, Fidelity and Sofinnova Partners, and 4 more on record. Venrock Healthcare Capital Partners led its latest round.

### How much has CellCentric raised?

CellCentric has raised $525M across 8 rounds since 2013.

### When did CellCentric last raise?

CellCentric's most recent round was a Growth of $220M in May 2026, led by Venrock Healthcare Capital Partners.

### What was CellCentric's biggest round?

Its most recent round, $220M in May 2026, is also its largest on record.

### Who backed CellCentric first?

CellCentric's first round on record, in May 2025, was backed by RA Capital Management, Forbion Capital Partners and Avego Bioscience Capital and 1 others.

### What stage is CellCentric at?

CellCentric's latest named round is a Growth, in May 2026.

### Where is CellCentric based?

CellCentric is based in the United Kingdom.

### Who led CellCentric's rounds?

RA Capital Management led the Series C in 2025; Venrock Healthcare Capital Partners led the Growth in 2026.

## Companies like CellCentric

In the same sector, and raised in the last eighteen months.

[**Coherence Neuro** $55M · Oct 2026](https://millionrounds.com/company/coherence-neuro)[**HydRegen** $12M · Oct 2026](https://millionrounds.com/company/hydregen)[**XRlabs** $8.4M · Oct 2026](https://millionrounds.com/company/xrlabs)[**OMass Therapeutics** $442M · Oct 2026](https://millionrounds.com/company/omass-therapeutics)[**CMR Surgical** $1.1B · Oct 2026](https://millionrounds.com/company/cmr-surgical)[**MintNeuro** $26M · Oct 2026](https://millionrounds.com/company/mintneuro)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app